Sign in

Lenka Vodstrcil

@lenkavod.bsky.social
7 followers 12 following 9 posts

Senior Research Fellow #SexualHealth #Epidemiology at School of Translational Medicine, Monash University Deputy Head, Genital Microbiome and Mycoplasma group President, Sexual Health Society of Victoria

PostsRepliesMedia
Lenka Vodstrcil @lenkavod.bsky.social · 01/10/2026
Our paper in @lancetobgyn-wh.bsky.social explores bacterial vaginosis recurrence. In a cohort of treated couples we found two pathways drive repeat BV: reinfection, mitigated with partner treatment; & persistence, which may require more intensive treatments for women doi.org/10.1016/S305...
thelancet.com
Determinants of repeat bacterial vaginosis in concurrently treated couples: a post-hoc pooled cohort study
In a proportion of women, bacterial vaginosis is not cleared early, after receipt of antibiotics and before resumption of sex. To improve cure rates, women with persistent bacterial vaginosis after tr...
021
Lenka Vodstrcil @lenkavod.bsky.social · 17/08/2026
We are so thrilled to be named as a finalist for the AIDRC Eureka Prize for #InfectiousDiseases research! We look forward to joining our fellow finalists at the awards event on Sept 3rd A special thanks to our MSHC colleagues, collaborators and study participants ❤️ @monashuniversity.bsky.social
010
Reposted by Lenka Vodstrcil
ACOG @acog.org · 17/10/2025
ACOG’s new Clinical Practice Update on bacterial vaginosis (BV) treatment explores new data and increasing evidence supporting the efficacy of sexual partner therapy in reducing recurrences of BV. Learn more: bit.ly/4qgja4X
041
Reposted by Lenka Vodstrcil
Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · 25/06/2025
Treatment strategies for #BacterialVaginosis include eliminating harmful bacteria, restoring optimal microbiota and preventing sexual transmission. Achieving sustained cure likely requires a tailored, multi-strategy plan. #WomensHealth #medsky www.nature.c...
A schematic summarizing management approaches for bacterial vaginosis.
142
Reposted by Lenka Vodstrcil
Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · 25/06/2025
#BacterialVaginosis is associated with an interconnected morbidity profile, including HPV infection and cervical carcinogenesis, increased risk of sexually transmitted diseases, and gynaecological and obstetric complications. #WomensHealth #obgynsky www.nature.c...
A poster highlighting epidemiology and morbidities associated with bacterial vaginosis.
052
Reposted by Lenka Vodstrcil
Alicia King (she/her) @aliciajeanking.bsky.social · 17/03/2025
It's no exaggeration to call this a paradigm shift... But what do people need to know when considering if partner treatment is right for them? ...and what do they need from #healthcare providers? Find out what trial participants said in our new @springernature.com #publication: rdcu.be/edCJ9
072
Lenka Vodstrcil @lenkavod.bsky.social · 25/06/2025
We also outlined all of the obstetric and gynaecologic sequelae associated with BV. The mechanisms underpinning these associations are also included in our BV Primer
020
Lenka Vodstrcil @lenkavod.bsky.social · 25/06/2025
Our Primer presents the latest evidence on the pathogenesis of bacterial vaginosis (BV). We included a hypothetical model of how the formation of a BV-biofilm occurs following vaginal colonisation with key BV-associated bacteria. View our @natrevdiseaseprimers.nature.com on BV to find out more!
130
Reposted by Lenka Vodstrcil
Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · 21/06/2025
#BacterialVaginosis affects ~26% of the population globally, with regional variation. It is most common in resource-limited areas and women living with HIV, and vaginal microbial communities vary by location and population. #WomensHealth www.nature.c...
Three bar charts showing the estimated prevalence of bacterial vaginosis In different populations.
173
Lenka Vodstrcil @lenkavod.bsky.social · 20/06/2025
This PrimeView provides a lovely overview of our paper and is free to download this week! Find out the latest in BV research and what we still need to find out to improve health outcomes for all women with BV.
020
Reposted by Lenka Vodstrcil
Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · 19/06/2025
Our NEW Primer on Bacterial vaginosis is live today! By Bradshaw, Plummer, Muzny, Mitchell, Fredricks, Herbst-Kralovetz & Vodstrcil @lenkavod.bsky.social‬ 🦠 #microbiome #WomensHealth Check it out here ⬇️
nature.com
Bacterial vaginosis - Nature Reviews Disease Primers
Bacterial vaginosis is a vaginal microbiome disorder that is associated with serious obstetric and gynaecologic complications and negative effects on quality of life. In this Primer, Bradshaw et al. review the epidemiology, pathophysiology, diagnosis and management of bacterial vaginosis, discuss its effects on quality of life and highlight areas for research.
023
Reposted by Lenka Vodstrcil
Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · 19/06/2025
Get Primed on Bacterial vaginosis with our NEW PrimeView! FREE to download this week! #WomensHealth #microbiome 🦠 www.nature.c...
A poster highlighting the epidemiology and co-morbidities of bacterial vaginosis.
154
Lenka Vodstrcil @lenkavod.bsky.social · 20/06/2025
Our Nature Primer on Bacterial vaginosis is out now in @springernature.com journal @natrevdiseaseprimers.nature.com We provide an overview of the latest #BV research and key knowledge gaps in BV aetiology, diagnostics & treatment. read it here: rdcu.be/erOxg I loved working with this team!
rdcu.be
Bacterial vaginosis
Nature Reviews Disease Primers - Bacterial vaginosis is a vaginal microbiome disorder that is associated with serious obstetric and gynaecologic complications and negative effects on quality of...
130
Lenka Vodstrcil @lenkavod.bsky.social · 24/03/2025
The #StepUp male partner treatment trial recently published @nejm.org showed that treating the male partners of women with #bacterialvaginosis at the same time reduced BV recurrence rates out to 12 weeks. For men we used a combination of topical and oral antibiotics (or no treatment for controls).
000